Summary
Overview
Work History
Education
Skills
References
Languages
Timeline

MICHAEL CODY

Dallas,TX

Summary


Professional leader with executive experience ready to drive impactful change. Proven ability to implement strategic initiatives and enhance operational performance. Valued for collaborative team leadership and adaptability to evolving business needs. Profound areas of expertise include: Nephrology, CNS, Women’s Health Care, Cardiovascular/Heart Failure, Iron/Anemia management, Pain Management, Inflammation, Stroke, and Wound Care, and Rare Disease.

Overview

20
20
years of professional experience

Work History

Vice President and Head of Medical Affairs

SHIELD THERAPEUTICS, Plc
01.2021 - 01.2024
  • Reported directly to the CEO
  • Responsible for the creation, development, and execution of all US medical affairs strategic initiatives and medical operating plans to successfully support Shield’s business goals
  • Responsible for the medical affairs budget of $4 million dollars, working with the CMO and CFO to ensure efficient and effective allocation of resources for medical affairs
  • Clearly and skillfully aligned medical strategies with changing commercial focuses by providing outstanding clinical leadership and guidance both to the medical team and with cross-functional partners
  • Worked closely and compliantly with VP of Clinical Development, VP of Marketing and VP of Commercial
  • Responsible for and supervised all initiatives in Medical Education, creating 5, high-impact CMEs in our key KOL universe including: Women’s Health, OBGYN, and Primary Care
  • Co-created and co-moderated with NPWH, 2 highly successful and impactful educational trainings (Fireside Chats) featuring prominent thought leaders in both Primary Care and Women’s Health
  • Also responsible for the sponsorship, creation and co-moderation of 8 advisory boards, providing Shield with key insights and competitive intel from key Thought Leaders in our scope of practice and patient care
  • Responsible for the creation, development, and execution of Shield’s publication plan, gaining the acceptance of 4 abstracts, 2 poster presentations and multiple publications
  • Responsible for identifying and fostering strong, relationships with key Thought Leaders within iron deficiency, iron deficiency anemia, Women’s Health, and Primary Care
  • Responsible for the management and oversight of US medical information and communication, working collaboratively with the UK Head of Medical Information and the medical information vendor and budgets
  • Represented Shield externally to all medical/clinical societies such as ACOG, NPWH, AANP, FMX, advocating for the underserved and unmet medical need of iron deficiency and iron deficiency anemia, fostering strong, strategic partnerships in advancement of needed medical initiatives
  • Worked closely with the VP of Clinical Development to review and oversee the current post-marking studies as well as support for global partners with studies and planned launches
  • Responsible for leading, training, on-boarding, and management of the MSL team and all field Medical Affairs initiatives
  • Acted as sole medical reviewer for the Medical/Legal Review (MLR) committee

Executive Director, Medical Science Team

RELYPSA, INC, a VIFOR PHARMA COMPANY
01.2017 - 01.2021
  • Responsible for a team of 17, including: 14 Medical Science Directors (MSD); 2 Regional MSD Team leads; and one Training and Operations Director
  • Successfully hired and promoted 2 MSDs to Regional Team Leader positions
  • Responsible for a budget of $15 million dollars
  • Successfully managed and led the entire MSA team in the launch of a new co-promoted product
  • Lead the development and execution of all medical strategies for the MSD team, supporting the Medical Affairs’ Operating Plan (MOP)
  • Lead the development and implementation of processes to successfully identify, establish, and maintain collaborative relationships with Key Opinion Leaders (KOLs) including hyperkalemia, Nephrology, Heart Failure, and Endocrinology experts
  • Created curriculum and oversaw the training efforts for every member of the field medical team
  • Ensured efficient and effective cross-functional collaboration between the MSD team and internal departments such as Drug Safety, Clinical Development, Regulatory/Legal/Compliance, and Commercial and Marketing
  • Created and implemented the first MSD career ladder and development program for the MSD/MSA teams
  • Provided and supported global medical training for Vifor Pharma medical and commercial teams

Senior Medical Science Director, WEST Team Lead

RELYPSA, INC, a VIFOR PHARMA COMPANY
01.2016 - 01.2017
  • Recognized as a strong leader in the company via promotion to Executive Director, Field Medical team
  • Managed a team of 7 MSDs, covering the western half of the United States, including hiring and firing responsibilities
  • Worked with Executive Director and senior MSA leadership team to develop and manage a robust KOL network
  • Responsible for developing strategies specific to the West MSD team to support the successful execution of Medical Affairs strategies, tactics, and MOP
  • Worked effectively with cross-functional internal partners including Drug Safety, Clinical Development, Regulatory/Legal/Compliance, and Commercial and Marketing
  • Developed and maintained a comprehensive understanding of scientific/clinical data related to hyperkalemia treatment and other associated disorders
  • Developed and maintained on-boarding, training, and mentorship programs for the team
  • One of the first Relypsa employees to be accepted into and successfully complete the Vifor Pharma Management Program (VPMP2, 2017)

Medical Science Director

RELYPSA, INC.
01.2015 - 01.2016
  • Recognized as a rising leader within the company via promotion to Senior MSD, West Team Leader
  • Developed and maintained clinical knowledge expertise in the hyperkalemia treatment landscape including current treatment strategies, and new therapeutic developments
  • Organized and lead weekly MSD journal club teleconferences and executed detailed summaries to team
  • Developed and ensured alignment in medical education activities for healthcare professionals through MSD-delivered presentations; participation in medical meetings; and, other appropriate venues to enhance product and disease state knowledge
  • Collaborated with the Relypsa clinical team, medical monitors and CRA's to coordinate and optimize educational and research support for sites/investigators participating in Relypsa’s clinical trials
  • Served as liaison to KOLs submitting investigator sponsored studies (IIS)
  • Ensured alignment on content of effective clinical presentations provided to internal and external audiences, ensuring presentations are tailored to meet the specific needs of the audience
  • Identify educational needs within the medical community around hyperkalemia disease state management
  • Acted as peer leader and mentor for newly onboarded MSDs
  • Awarded SPOT award for recognition as a leader among the MSD team (2015)
  • Awarded a Values in Action, Achievement through Excellence award (2015)

Medical Science Liaison

HYPERION THERAPEUTICS
01.2014 - 01.2015
  • Established professional relationships with thought leaders, academic institutions, and managed care communities in the field of genetics and metabolic disorders
  • Presented critical medical and scientific information to KOLs to address proactive and reactive unmet medical educational needs
  • Collaborated with cross-functional teams to develop strategies to assess the education and research needs within the rare disease community
  • Assisted in the identification of investigators and sites for company trials
  • Served as a liaison for the review, submission, execution, completion of IIS (Investigator Initiated Studies) proposals and facilitate the initiation of research projects
  • Organized, led, and represented the company at key scientific meetings such as the Society for the Study of Inborn Errors of Metabolism (SSIEM 2014), Innsbruck, Austria

Medical Science Liaison

SANOFI (Formerly GENZYME)
01.2010 - 01.2013
  • Established, cultivated, and leveraged relationships with Global, National, and Regional KOLs around clinical and medical practice and research regarding Chronic Kidney Disease (CKD) and Mineral and Bone Disorder (MBD)
  • Supported and moderated advisory board meetings and speaker training initiatives
  • Maintained cross-functional collaborations with internal customers such as Global Marketing, Global Medical Communications, US Marketing, and Sales
  • Active member of the following committees: Scientific Review Committee, Medical Review Committee, Publication Review Committee, and Commercial Review Committee
  • Created, planned, and conducted global training for both medical affairs and sales colleagues in the United Kingdom
  • Successfully completed a preceptorship with our Global Medical Communications department to organize and deliver 3 medical consultants’ forms in Hong Kong, Madrid, and Istanbul
  • Delivered medical presentations to diverse audiences including renal nephrologists, renal fellows, regional dietitians, and pharmacists
  • Represented KOLs with their Investigator Initiated Studies (IST) through our Medical Research Committee
  • Contributed to publication planning, and development of medical education and materials for internal training
  • Participated in one-on-one mentoring of new MSLs
  • Awarded a SPOT achievement award from the Global Marketing team for innovation and collaboration

Medical Science Liaison/Clinical Science Consultant

BOEHRINGER INGELHEIM PHARMACEUTICALS
01.2009 - 01.2010
  • Provided educational consultations to Key Opinion Leaders including Pulmonologists, Neurologists, and Primary Care Physicians
  • Present in-depth, on-label, and fair-balanced clinical information to targets, including Key Opinion Leaders, focusing on Chronic Obstructive Pulmonary Disease (COPD), Transient Ischemic Attacks (TIAs) and secondary stroke prevention including: diagnosis, management, and treatment
  • Actively seeking out and creating strong KOL relationships through literature searches; attending conferences and symposiums; and researching teaching hospitals and institutions
  • Demonstrated proficiency in pre-call planning and travel planning to reach and service a territory covering 100 Key Opinion Leaders, covering 5 states

Clinical Science Consultant

PFIZER INC.
01.2008 - 01.2009
  • Managed a territory consisting of 80 CNS Key Opinion Leaders representing Pfizer for clinical information on 3 billion-dollar drugs: Aricept, Celebrex, and Lyrica
  • Worked extensively as a Medical Consultant with these drugs in the specialty areas of Pain Management and Inflammation and CNS
  • Traveled daily to facilitate clinical discussions and conduct workshops with KOLs and acted as a consultant to physicians and Key Opinion Leaders, creatively exercising my clinical knowledge, sales, and marketing background to meet their needs and exceed expectations
  • Created and executed marketing plans to maximize interactions with physicians and Key Opinion Leaders

Clinical Specialist/Medical Sales Liaison

PAJUNK MEDICAL DEVICE SYSTEMS
01.2007 - 01.2008
  • Company Overview: (Specializing in Regional Anesthesiology: creators of the world-renowned, Sprotte Spinal Needle)
  • Traveled nationally and globally to market and present information to Key Opinion Leaders on medical systems products: major areas of expertise in Pain Management
  • Focused daily on building and maintaining a strong KOL constituency
  • Supported international trade shows and medical conferences, and congresses
  • Actively communicated with Vice Presidents of both Research and Development and Medical Affairs to gain extensive knowledge of our company and our products to create valuable training tools to expand product knowledge for medical and sales teams
  • Lead the first US marketing campaign in promotion of Pajunk’s number one product, the Sprotte Spinal Needle
  • (Specializing in Regional Anesthesiology: creators of the world-renowned, Sprotte Spinal Needle)

Medical Student/Resident Doctor

UNC-CH SCHOOL OF MEDICINE
01.1995 - 01.2002
  • Highly trained in all areas of Anesthesiology including general, regional, and pain management
  • Organized and executed daily surgical plans and monitored vital signs in preparation for patient discharge, reported to Chairman of Surgery
  • Highly trained in the usage of surgical supplies, instrumentation, and most operating room materials
  • Trained in neurosurgical, surgical, neonatal, pediatric, and cardiac critical care environments
  • Supervised 10 - 15 first-year residents in extremely complex procedures in Anesthesiology, ranking me in the top 1% of my class in excellence of execution and leadership

Clinical Research Assistant, Orthopedic Physiology

BOWMAN GRAY SCHOOL OF MEDICINE
01.1994 - 01.1995
  • Studied the microcirculation in rabbit ears as a model for human hands and feet in such disorders as Raynaud's phenomenon
  • Developed and presented research finding to department heads and faculty
  • Experienced in program management; writing patient summaries; and publishing charts

Education

M.D. -

University of North Carolina At Chapel Hill School of Medicine, Chapel Hill, NC

Maher Medical Community Service Honor Society Inductee

AED Pre-med Honor Society

Dean's List

BS - Biology, Pre-Med, and French minor

Wake Forest University, Winston-Salem, NC
  • Cum Laude
  • National Pre-Medical Honor Society
  • Dean’s List
  • Resident Advisor, senior year
  • Sports Medicine trainer, senior year
  • National Golden Key Honor Society

Skills

  • Strategic thinking and planning
  • Business development
  • Data analysis
  • Budget oversight
  • Verbal and written communication
  • Innovation management
  • Team leadership
  • Relationship building
  • Decision-making
  • Critical thinking

References

References and publications available upon request.

Languages

French
Limited Working

Timeline

Vice President and Head of Medical Affairs - SHIELD THERAPEUTICS, Plc
01.2021 - 01.2024
Executive Director, Medical Science Team - RELYPSA, INC, a VIFOR PHARMA COMPANY
01.2017 - 01.2021
Senior Medical Science Director, WEST Team Lead - RELYPSA, INC, a VIFOR PHARMA COMPANY
01.2016 - 01.2017
Medical Science Director - RELYPSA, INC.
01.2015 - 01.2016
Medical Science Liaison - HYPERION THERAPEUTICS
01.2014 - 01.2015
Medical Science Liaison - SANOFI (Formerly GENZYME)
01.2010 - 01.2013
Medical Science Liaison/Clinical Science Consultant - BOEHRINGER INGELHEIM PHARMACEUTICALS
01.2009 - 01.2010
Clinical Science Consultant - PFIZER INC.
01.2008 - 01.2009
Clinical Specialist/Medical Sales Liaison - PAJUNK MEDICAL DEVICE SYSTEMS
01.2007 - 01.2008
Medical Student/Resident Doctor - UNC-CH SCHOOL OF MEDICINE
01.1995 - 01.2002
Clinical Research Assistant, Orthopedic Physiology - BOWMAN GRAY SCHOOL OF MEDICINE
01.1994 - 01.1995
University of North Carolina At Chapel Hill School of Medicine - M.D.,
Wake Forest University - BS, Biology, Pre-Med, and French minor
MICHAEL CODY